JAMES C YAO to Aspartate Aminotransferases
This is a "connection" page, showing publications JAMES C YAO has written about Aspartate Aminotransferases.
Connection Strength
0.049
-
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022 03; 7(3):208-218.
Score: 0.049